EUVIMEDEUVIMED entdecken
Crossref

Mechanisms of Addiction: Understanding How Serotonin Signaling Modulates Opioid-Induced Dopamine Release and Addictive Behavior

Kathryn T Mattox, Boris Dov Heifets, Liqun Luo, Julie A. Kauer, Stanford University

Stanford Digital Repository · 30.04.2026

DOI: 10.25740/dw434qd4120 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Stanford Digital Repository, erschienen am 30.04.2026. Verfasst von Kathryn T Mattox und 4 weiteren Autor:innen.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Opioids are widely prescribed to relieve pain, but have high addictive potential due in part to their ability to increase dopamine release in mesolimbic reward circuits. Serotonin signaling is thought to modulate opioid signaling and dopamine release and may mitigate the addictive properties of opioids, including risk of relapse and withdrawal. However, the mechanisms behind this interaction are poorly understood. Preliminary data from our research group suggests that global serotonin release caused by the serotonin-releasing drug (-)-fenfluramine can block opioid-driven addictive behaviors while paradoxically potentiating dopamine release. This finding challenges the prevailing assumption that dopamine release is sufficient to drive addictive behavior and suggests a role for specific serotonin (5-HT) receptor subtypes in decoupling dopamine release from drug reward. Using in vivo fluorescent dopamine reporters and conditioned place preference (CPP) behavioral assays in mice, this study evaluates the effect of specific 5-HT receptor subtype signaling (5-HT1A, 5-HT2A, and 5-HT2B) on opioid-induced dopamine release in the nucleus accumbens (NAc) and addictive behavior. We found that activation of the 5-HT1A receptor increases morphine-induced dopamine release, however it did not block morphine-induced place preference. These results provide insight into how serotonin signaling can be used to modulate the neurobiological pathways of opioid addiction and indicate that targeting the 5-HT1A receptor may not have therapeutic potential in treating opioid addiction.

Schlagwörter

opioid use disorderserotonin signalingdopamine release5-HT1A receptor5-HT2A receptor5-HT2B receptormorphinenucleus accumbensconditioned place preferencefenfluramine

Zitieren

APA

Mattox, K. T., Heifets, B. D., Luo, L., Kauer, J. A., & University, S. (2026). Mechanisms of Addiction: Understanding How Serotonin Signaling Modulates Opioid-Induced Dopamine Release and Addictive Behavior. Stanford Digital Repository. https://doi.org/10.25740/dw434qd4120

Vancouver

Mattox KT, Heifets BD, Luo L, Kauer JA, University S. Mechanisms of Addiction: Understanding How Serotonin Signaling Modulates Opioid-Induced Dopamine Release and Addictive Behavior. Stanford Digital Repository. 2026. doi:10.25740/dw434qd4120

BibTeX
@article{Mattox2026,
  author = {Mattox, Kathryn T and Heifets, Boris Dov and Luo, Liqun and Kauer, Julie A. and University, Stanford},
  title = {Mechanisms of Addiction: Understanding How Serotonin Signaling Modulates Opioid-Induced Dopamine Release and Addictive Behavior},
  journal = {Stanford Digital Repository},
  year = {2026},
  doi = {10.25740/dw434qd4120}
}
Kostenlos starten →